1 Friedman, JM (2009) Obesity: causes and control of excess body fat. Nature 459, 340–342.
2 Chang, S, Graham, B, Yakubu, F, et al. (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 259, R1103–R1110.
3 Levin, BE, Hogan, S & Sullivan, AC (1989) Initiation and perpetuation of obesity and obesity resistance in rats. Am J Physiol 256, R766–R771.
4 Levin, BE & Sullivan, AC (1987) Glucose, insulin and sympathoadrenal activation. J Auton Nerv Syst 20, 233–242.
5 Flanagan, AM, Brown, JL, Santiago, CA, et al. (2008) High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem 19, 505–513.
6 Ramis, JM, Bibiloni, B, Moreiro, J, et al. (2005) Tissue leptin and plasma insulin are associated with lipoprotein lipase activity in severely obese patients. J Nutr Biochem 16, 279–285.
7 Levin, BE (1991) Glucose increases rat plasma norepinephrine levels by direct action on the brain. Am J Physiol 261, R1351–R1357.
8 Levin, BE, Triscari, J & Sullivan, AC (1983) Altered sympathetic activity during development of diet-induced obesity in rat. Am J Physiol 244, R347–R355.
9 Alexander, J, Chang, GQ, Dourmashkin, JT, et al. (2006) Distinct phenotypes of obesity-prone AKR/J, DBA2J and C57BL/6J mice compared to control strains. Int J Obes (Lond) 30, 50–59.
10 Abou Mrad, J, Yakubu, F, Lin, D, et al. (1992) Skeletal muscle composition in dietary obesity-susceptible and dietary obesity-resistant rats. Am J Physiol 262, R684–R688.
11 Eberhart, GP, West, DB, Boozer, CN, et al. (1994) Insulin sensitivity of adipocytes from inbred mouse strains resistant or sensitive to diet-induced obesity. Am J Physiol 266, R1423–R1428.
12 Levin, BE, Finnegan, MB, Marquet, E, et al. (1984) Defective brown adipose oxygen consumption in obese Zucker rats. Am J Physiol 247, E94–E100.
13 Li, H, Xie, Z, Lin, J, et al. (2008) Transcriptomic and metabonomic profiling of obesity-prone and obesity-resistant rats under high fat diet. J Proteome Res 7, 4775–4783.
14 Ji, H & Friedman, MI (2008) Reduced hepatocyte fatty acid oxidation in outbred rats prescreened for susceptibility to diet-induced obesity. Int J Obes (Lond) 32, 1331–1334.
15 Jackman, MR, Kramer, RE, MacLean, PS, et al. (2006) Trafficking of dietary fat in obesity-prone and obesity-resistant rats. Am J Physiol Endocrinol Metab 291, E1083–E1091.
16 Hu, CC, Qing, K & Chen, Y (2004) Diet-induced changes in stearoyl-CoA desaturase 1 expression in obesity-prone and -resistant mice. Obes Res 12, 1264–1270.
17 Gazzana, G & Borlak, J (2009) An update on the mouse liver proteome. Proteome Sci 7, 35.
18 Chinese Human Liver Proteome Profiling Consortium (2010) First insight into human liver proteome from PROTEOME(SKY)-LIVER(Hu) 1.0, a publicly available database. J Proteome Res 9, 79–94.
19 Thome-Kromer, B, Bonk, I, Klatt, M, et al. (2003) Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 3, 1835–1862.
20 Gazzana, G & Borlak, J (2007) Improved method for proteome mapping of the liver by 2-DE MALDI-TOF MS. J Proteome Res 6, 3143–3151.
21 Shi, R, Kumar, C, Zougman, A, et al. (2007) Analysis of the mouse liver proteome using advanced mass spectrometry. J Proteome Res 6, 2963–2972.
22 Song, Y, Hao, Y, Sun, A, et al. (2006) Sample preparation project for the subcellular proteome of mouse liver. Proteomics 6, 5269–5277.
23 Zhang, X, Yang, J, Guo, Y, et al. (2010) Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis. Hepatology 51, 1190–1199.
24 Eccleston, HB, Andringa, KK, Betancourt, AM, et al. (2011) Chronic exposure to a high fat diet induces hepatic steatosis, impairs nitric oxide bioavailability, and modifies the mitochondrial proteome in mice. Antioxid Redox Signal (epublication ahead of print version 31 March 2011).
25 Jiang, L, Wang, Q, Yu, Y, et al. (2009) Leptin contributes to the adaptive responses of mice to high-fat diet intake through suppressing the lipogenic pathway. PLoS One 4, e6884.
26 de Roos, B, Rungapamestry, V, Ross, K, et al. (2009) Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9, 3244–3256.
27 Folch, J, Lees, M & Sloane Stanley, GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497–509.
28 Nepokroeff, CM, Lakshmanan, MR & Porter, JW (1975) Fatty-acid synthase from rat liver. Methods Enzymol 35, 37–44.
29 Ochoa, S (1995) Malic enzyme: mallic enzymes from pigeon and wheat germ. In Methods in Enzymmology, pp. 323–326 [Colowick, SP and Kaplan, NO, editors]. New York: Academic Press.
30 Lazarow, PB (1981) Assay of peroxisomal beta-oxidation of fatty acids. Methods Enzymol 72, 315–319.
31 Markwell, MA, McGroarty, EJ, Bieber, LL, et al. (1973) The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J Biol Chem 248, 3426–3432.
32 Bradford, MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248–254.
33 Kim, SW, Hwang, HJ, Baek, YM, et al. (2008) Proteomic and transcriptomic analysis for streptozotocin-induced diabetic rat pancreas in response to fungal polysaccharide treatments. Proteomics 8, 2344–2361.
34 Kumar, SG, Rahman, MA, Lee, SH, et al. (2009) Plasma proteome analysis for anti-obesity and anti-diabetic potentials of chitosan oligosaccharides in ob/ob mice. Proteomics 9, 2149–2162.
35 Shevchenko, A, Tomas, H, Havlis, J, et al. (2006) In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1, 2856–2860.
36 Fernandez, J, Gharahdaghi, F & Mische, SM (1998) Routine identification of proteins from sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels or polyvinyl difluoride membranes using matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS). Electrophoresis 19, 1036–1045.
37 Sanchez, JC, Converset, V, Nolan, A, et al. (2003) Effect of rosiglitazone on the differential expression of obesity and insulin resistance associated proteins in lep/lep mice. Proteomics 3, 1500–1520.
38 Moller, DE (2001) New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414, 821–827.
39 Zibrova, D, Grempler, R, Streicher, R, et al. (2008) Inhibition of the interaction between protein phosphatase 1 glycogen-targeting subunit and glycogen phosphorylase increases glycogen synthesis in primary rat hepatocytes. Biochem J 412, 359–366.
40 Alemzadeh, R, Holshouser, S, Massey, P, et al. (2002) Chronic suppression of insulin by diazoxide alters the activities of key enzymes regulating hepatic gluconeogenesis in Zucker rats. Eur J Endocrinol 146, 871–879.
41 Aiston, S, Peak, M & Agius, L (2000) Impaired glycogen synthesis in hepatocytes from Zucker fatty fa/fa rats: the role of increased phosphorylase activity. Diabetologia 43, 589–597.
42 Lehner, R & Verger, R (1997) Purification and characterization of a porcine liver microsomal triacylglycerol hydrolase. Biochemistry 36, 1861–1868.
43 Jernas, M, Olsson, B, Arner, P, et al. (2009) Regulation of carboxylesterase 1 (CES1) in human adipose tissue. Biochem Biophys Res Commun 383, 63–67.
44 Soni, KG, Lehner, R, Metalnikov, P, et al. (2004) Carboxylesterase 3 (EC 188.8.131.52) is a major adipocyte lipase. J Biol Chem 279, 40683–40689.
45 Duffel, MW & Jakoby, WB (1981) On the mechanism of aryl sulfotransferase. J Biol Chem 256, 11123–11127.
46 Ringer, DP, Norton, TR & Howell, BA (1990) 2-Acetylaminofluorene-mediated alteration in the level of liver arylsulfotransferase IV during rat hepatocarcinogenesis. Cancer Res 50, 5301–5307.
47 Wraith, JE (2001) Ornithine carbamoyltransferase deficiency. Arch Dis Child 84, 84–88.
48 Yamini, S, Staples, RC, Hansen, CT, et al. (1991) Effect of dietary carbohydrate on liver and kidney enzyme activities and plasma amino acids in the LA/N-cp rat. Int J Obes 15, 189–203.
49 Haketa, A, Soma, M, Nakayama, T, et al. (2004) Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens 22, 1903–1907.
50 Li, LO, Mashek, DG, An, J, et al. (2006) Overexpression of rat long chain acyl-coa synthetase 1 alters fatty acid metabolism in rat primary hepatocytes. J Biol Chem 281, 37246–37255.
51 Schlesinger, MJ (1990) Heat shock proteins. J Biol Chem 265, 12111–12114.
52 Kim, S, Sohn, I, Ahn, JI, et al. (2004) Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340, 99–109.
53 Tsukahara, F, Yoshioka, T & Muraki, T (2000) Molecular and functional characterization of HSC54, a novel variant of human heat-shock cognate protein 70. Mol Pharmacol 58, 1257–1263.
54 Egerton, M, Moritz, RL, Druker, B, et al. (1996) Identification of the 70 kD heat shock cognate protein (Hsc70) and alpha-actinin-1 as novel phosphotyrosine-containing proteins in T lymphocytes. Biochem Biophys Res Commun 224, 666–674.
55 Gaston, JS (2002) Heat shock proteins and innate immunity. Clin Exp Immunol 127, 1–3.
56 Kim, DH, Joo, JI, Choi, JW, et al. (2010) Differential expression of skeletal muscle proteins in high-fat diet-fed rats in response to capsaicin feeding. Proteomics 10, 2870–2881.
57 Lee, WH, Wheatley, W, Benedict, WF, et al. (1986) Purification, biochemical characterization, and biological function of human esterase D. Proc Natl Acad Sci U S A 83, 6790–6794.
58 Schreiber, R, Taschler, U, Wolinski, H, et al. (2009) Esterase 22 and beta-glucuronidase hydrolyze retinoids in mouse liver. J Lipid Res 50, 2514–2523.
59 Husson, A, Brasse-Lagnel, C, Fairand, A, et al. (2003) Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle. Eur J Biochem 270, 1887–1899.
60 Engel, K, Hohne, W & Haberle, J (2009) Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene. Hum Mutat 30, 300–307.
61 McLean, C, Greene, CM & McElvaney, NG (2009) Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency. Biologics 3, 63–75.
62 Kaushal, S, Annamali, M, Blomenkamp, K, et al. (2010) Rapamycin reduces intrahepatic alpha-1-antitrypsin mutant Z protein polymers and liver injury in a mouse model. Exp Biol Med (Maywood) 235, 700–709.
63 Nemeth, A (1994) Pathogenesis of liver disease in alpha 1-antitrypsin deficiency. Acta Paediatr Suppl 393, 5–7.
64 Decker, M, Arand, M & Cronin, A (2009) Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol 83, 297–318.
65 Morisseau, C & Hammock, BD (2005) Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45, 311–333.
66 Schmid, GM, Converset, V, Walter, N, et al. (2004) Effect of high-fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice. Proteomics 4, 2270–2282.
67 Hastings, IM & Hill, WG (1990) Analysis of lines of mice selected for fat content. 2. Correlated responses in the activities of enzymes involved in lipogenesis. Genet Res 55, 55–61.
68 Lavoie, JM & Gauthier, MS (2006) Regulation of fat metabolism in the liver: link to non-alcoholic hepatic steatosis and impact of physical exercise. Cell Mol Life Sci 63, 1393–1409.
69 Lage, R, Dieguez, C, Vidal-Puig, A, et al. (2008) AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14, 539–549.
70 Kahn, BB, Alquier, T, Carling, D, et al. (2005) AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1, 15–25.
71 Woods, A, Azzout-Marniche, D, Foretz, M, et al. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20, 6704–6711.
72 Nguyen, P, Leray, V, Diez, M, et al. (2008) Liver lipid metabolism. J Anim Physiol Anim Nutr (Berl) 92, 272–283.
73 Baffy, G (2005) Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10, 2082–2096.
74 Horimoto, M, Fulop, P, Derdak, Z, et al. (2004) Uncoupling protein-2 deficiency promotes oxidant stress and delays liver regeneration in mice. Hepatology 39, 386–392.
75 Negre-Salvayre, A, Hirtz, C, Carrera, G, et al. (1997) A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 11, 809–815.
76 Arsenijevic, D, Onuma, H, Pecqueur, C, et al. (2000) Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 26, 435–439.
77 Petzke, KJ, Riese, C & Klaus, S (2007) Short-term, increasing dietary protein and fat moderately affect energy expenditure, substrate oxidation and uncoupling protein gene expression in rats. J Nutr Biochem 18, 400–407.